BTIG on United Therapeutics Corp. (UTHR): 'We believe Yutrepia likely sees positive readthrough from this data'
Tweet Send to a Friend
BTIG analyst Julian Harrison reiterated a Neutral rating and {REMOVEPT} price target on United Therapeutics Corp. (NASDAQ: UTHR).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
